Safe The Renal To Perform Better
Taurine 250mg+ N-Acetylcystine 600mg+ L-Methylfolate 300mcg+ Resceratrol 200mg+ Ganoderma 100mg Softgel Capsuel
Taurine :
* Acts as an antioxidant in a variety in vivo and in vitro system prevents lipid per oxidation of glomerular meningeal cells and renal tubular epithelial cells expose to high glucose or hypoxic culture condition.
* Taurine provides protection against renal dysfunction including hyper tension, proteinuria, specific glomerular tubular disorder, acute and chronic renal condition and diabetic neuropathy.
N-Acetylcystine :
* Several studies shown that NAC reduce serum creatinine, increase the clearance of endogenous creatinine and improve the ultra structure of podocytes which delay the deterioration progress renal function.
* NAC plays important role in the detoxification of kidney and liver and help to prevent potential side Effects of drugs with environmental factors such as exposure to heavy metals that may impact organs.
* These results clearly indicate that NAC use to improve renal function in patients with CKD who consume NAC for one or two years.
* Therefore, NAC use should continue for 2 years for protection of renal function in patients with CKD.
* NAC used had no effect on renal function in the present study.
L-Methyl Folate :
* Reduces odds of chronic kidney diseases progression. CKD patient’s has higher cardiovascular risk then general population.
* A fact that has been linked to high hemocysteine levels l-methyl folate reduce hemocysteine levels which will reduce cardiovascular events.
* A daily dose of l-methyl foloate slow down the decline of renal function in people with CKD.
Resveratrol :
* Significantly improves oxidative damage by modulation of antioxidant enzyme and suppression of prooxidant factors in the kidney tissue of MHR ehanced antioxidant defence in the kidney improves renal function and ameliourates the morphological changes in this target organs.
* Resveratrol represent a promosing therapy at attenuate the progression of CKD affect azotemia and reduce mobidity and mortality by preventing or minimizing the risk of cardiovascular disease in patient with CKD.